Basic Information
| Terpenoid ID | TKC108536 |
|
| Cell line | 0 | |
| Protein target | 10 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 106 |
| Terpenoid ID | TKC108536 |
|
| Cell line | 0 | |
| Protein target | 10 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 106 |
| ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
|---|
| ID | Uniport | Pref_name | Gene name | value | unit | type |
|---|---|---|---|---|---|---|
| TKC108536 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 24337 | nM | Potency |
| TKC108536 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 68590 | nM | Potency |
| TKC108536 | P10828 | Thyroid hormone receptor beta | THRB | 44668 | nM | Potency |
| TKC108536 | P37231 | Peroxisome proliferator-activated receptor gamma | PPARG | 44668 | nM | Potency |
| TKC108536 | Q03181 | Peroxisome proliferator-activated receptor delta | PPARD | 2 | nM | Potency |
| TKC108536 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 17783 | nM | Potency |
| TKC108536 | P04637 | Cellular tumor antigen p53 | TP53 | 5 | nM | Potency |
| TKC108536 | Q96RI1 | Bile acid receptor | NR1H4 | 4 | nM | Potency |
| TKC108536 | Q9R1A7 | Nuclear receptor subfamily 1 group I member 2 | Nr1i2 | 12589 | nM | Potency |
| TKC108536 | Q07869 | Peroxisome proliferator-activated receptor alpha | PPARA | 50119 | nM | Potency |
| Uniport ID | Uniport Name | ICD-11 | Disease |
|---|---|---|---|
| Q16236 | NF2L2_HUMAN | ICD-11: 8A03 | disorder |
| Q16236 | NF2L2_HUMAN | ICD-11: 2C60-2C6Y | cancer |
| Q16236 | NF2L2_HUMAN | ICD-11: 9C61 | Glaucoma |
| Q16236 | NF2L2_HUMAN | ICD-11: 2C25 | cancer |
| Q16236 | NF2L2_HUMAN | ICD-11: 9B75 | degeneration |
| Q16236 | NF2L2_HUMAN | ICD-11: 2C30 | Melanoma |
| Q16236 | NF2L2_HUMAN | ICD-11: 6E20-6E8Z | disorder |
| Q16236 | NF2L2_HUMAN | ICD-11: BB01 | hypertension |
| Q16236 | NF2L2_HUMAN | ICD-11: 8B01 | haemorrhage |
| Q16236 | NF2L2_HUMAN | ICD-11: MF8Y | sympton |
| Q16236 | NF2L2_HUMAN | ICD-11: DB92 | disease |
| Q16236 | NF2L2_HUMAN | ICD-11: 5C5A | deficiency |
| Q16236 | NF2L2_HUMAN | ICD-11: 8B60 | disease |
| Q16236 | NF2L2_HUMAN | ICD-11: 8A40 | sclerosis |
| P10828 | THB_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
| P10828 | THB_HUMAN | ICD-11: 5A00 | Hypo-thyroidism |
| P10828 | THB_HUMAN | ICD-11: 5C52 | error |
| P10828 | THB_HUMAN | ICD-11: EL8Y | disorder |
| P10828 | THB_HUMAN | ICD-11: 5A02 | Thyrotoxicosis |
| P37231 | PPARG_HUMAN | ICD-11: BB01 | hypertension |
| P37231 | PPARG_HUMAN | ICD-11: 4A43 | syndrome |
| P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
| P37231 | PPARG_HUMAN | ICD-11: 5A2Y | complication |
| P37231 | PPARG_HUMAN | ICD-11: 8A20 | disease |
| P37231 | PPARG_HUMAN | ICD-11: 5B80-5B81 | Obesity |
| P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
| P37231 | PPARG_HUMAN | ICD-11: 5A10 | mellitus |
| P37231 | PPARG_HUMAN | ICD-11: 9C61 | Glaucoma |
| P37231 | PPARG_HUMAN | ICD-11: 5C52 | error |
| P37231 | PPARG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
| P37231 | PPARG_HUMAN | ICD-11: FA25 | Gout |
| P37231 | PPARG_HUMAN | ICD-11: DD72 | colitis |
| P37231 | PPARG_HUMAN | ICD-11: 8A40 | sclerosis |
| P37231 | PPARG_HUMAN | ICD-11: 6C4A | disorder |
| P37231 | PPARG_HUMAN | ICD-11: DB92 | disease |
| P37231 | PPARG_HUMAN | ICD-11: 6C43 | disorder |
| P37231 | PPARG_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
| P37231 | PPARG_HUMAN | ICD-11: CB03 | pneumonitis |
| P37231 | PPARG_HUMAN | ICD-11: 5C50-5D2Z | disorder |
| Q03181 | PPARD_HUMAN | ICD-11: DB92 | disease |
| Q03181 | PPARD_HUMAN | ICD-11: 5A11 | mellitus |
| Q03181 | PPARD_HUMAN | ICD-11: DB96 | disease |
| Q03181 | PPARD_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
| Q03181 | PPARD_HUMAN | ICD-11: 5B80-5B81 | Obesity |
| Q03181 | PPARD_HUMAN | ICD-11: 8A20 | disease |
| Q03181 | PPARD_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
| Q03181 | PPARD_HUMAN | ICD-11: 5C50-5D2Z | disorder |
| Q03181 | PPARD_HUMAN | ICD-11: 5A10 | mellitus |
| Q03181 | PPARD_HUMAN | ICD-11: 8A04-8D87 | disease |
| P19793 | RXRA_HUMAN | ICD-11: 2B57 | sarcoma |
| P19793 | RXRA_HUMAN | ICD-11: 2B01 | fungoides |
| P04637 | P53_HUMAN | ICD-11: BD40 | disease |
| P04637 | P53_HUMAN | ICD-11: 2B6E | neoplasm |
| P04637 | P53_HUMAN | ICD-11: 2D80 | neoplasm |
| P04637 | P53_HUMAN | ICD-11: NE84 | rejection |
| P04637 | P53_HUMAN | ICD-11: 5A80 | dysfunction |
| P04637 | P53_HUMAN | ICD-11: 2A60 | leukaemia |
| P04637 | P53_HUMAN | ICD-11: 2C94 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2A00 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2B91 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2B70 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2D42 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2A82 | leukaemia |
| P04637 | P53_HUMAN | ICD-11: 2A37 | syndrome |
| P04637 | P53_HUMAN | ICD-11: 2C73 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2C10 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
| P04637 | P53_HUMAN | ICD-11: 2B72 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2C77 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2C76 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2C74 | cancer |
| P04637 | P53_HUMAN | ICD-11: 2B59 | Liposarcoma |
| P04637 | P53_HUMAN | ICD-11: 2B33 | neoplasm |
| P04637 | P53_HUMAN | ICD-11: 2C51 | cancer |
| P04637 | P53_HUMAN | ICD-11: N.A. | Toxicity |
| P04637 | P53_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
| P04637 | P53_HUMAN | ICD-11: 2A60 | leukaemia |
| P04637 | P53_HUMAN | ICD-11: GB60-GB6Z | failure |
| P04637 | P53_HUMAN | ICD-11: AB50-AB57 | disorder |
| Q96RI1 | NR1H4_HUMAN | ICD-11: DB96 | disease |
| Q96RI1 | NR1H4_HUMAN | ICD-11: DC11 | Cholelithiasis |
| Q96RI1 | NR1H4_HUMAN | ICD-11: 7A00-7A0Z | Insomnia |
| Q96RI1 | NR1H4_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
| Q96RI1 | NR1H4_HUMAN | ICD-11: 2C60-2C6Y | cancer |
| Q96RI1 | NR1H4_HUMAN | ICD-11: DB92 | disease |
| Q96RI1 | NR1H4_HUMAN | ICD-11: GB61 | disease |
| Q96RI1 | NR1H4_HUMAN | ICD-11: LD24 | anomaly |
| Q96RI1 | NR1H4_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
| Q96RI1 | NR1H4_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
| Q96RI1 | NR1H4_HUMAN | ICD-11: 5A11 | mellitus |
| Q07869 | PPARA_HUMAN | ICD-11: BA00-BE2Z | disease |
| Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyperlipidemia |
| Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
| Q07869 | PPARA_HUMAN | ICD-11: 5C52 | error |
| Q07869 | PPARA_HUMAN | ICD-11: 5A11 | mellitus |
| Q07869 | PPARA_HUMAN | ICD-11: 5A10 | mellitus |
| Q07869 | PPARA_HUMAN | ICD-11: DB92 | disease |
| Q07869 | PPARA_HUMAN | ICD-11: 5A2Y | complication |
| Q07869 | PPARA_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
| Q07869 | PPARA_HUMAN | ICD-11: FA25 | Gout |
| Q07869 | PPARA_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
| Q07869 | PPARA_HUMAN | ICD-11: BD10-BD1Z | failure |
| Q07869 | PPARA_HUMAN | ICD-11: BD40 | disease |
| Q07869 | PPARA_HUMAN | ICD-11: CB03 | pneumonitis |
| Q07869 | PPARA_HUMAN | ICD-11: 5C50-5D2Z | disorder |
| Q07869 | PPARA_HUMAN | ICD-11: FA20 | arthritis |